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Abstract. The polypeptide composition of the U7 small
nuclear ribonucleoprotein (snRNP) involved in histone
messenger RNA (mRNA) 3¢ end formation has recently
been elucidated. In contrast to spliceosomal snRNPs,
which contain a ring-shaped assembly of seven so-called
Sm proteins, in the U7 snRNP the Sm proteins D1 and D2
are replaced by U7-specific Sm-like proteins, Lsm10 and
Lsm11. This polypeptide composition and the unusual
structure of Lsm11, which plays a role in histone RNA
processing, represent new themes in the biology of
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Sm/Lsm proteins. Moreover this structure has important
consequences for snRNP assembly that is mediated by
two complexes containing the PRMT5 methyltransferase
and the SMN (survival of motor neurons) protein, re-
spectively. Finally, the ability to alter this polypeptide
composition by a small mutation in U7 snRNA forms the
basis for using modified U7 snRNA derivatives to alter
specific pre-mRNA splicing events, thereby opening up a
new way for antisense gene therapy.
Key words. Histone RNA 3¢ end processing; U7 small nuclear ribonucleoprotein; Sm-like proteins; SMN complex;
symmetrical dimethyl arginine; Sm core assembly; Cajal bodies; antisense gene therapy; alternative splicing.
Introduction
The U7 small nuclear ribonucleoprotein (snRNP) is an
essential factor for the maturation of animal replication-
dependent histone messenger RNAs (mRNAs). As their
name implies, these mRNAs are regulated during the cell
cycle, with maximal levels being present during S phase.
Features distinguishing them from all other mRNAs are
their lack of introns and poly(A) tails. Their 3¢ ends are
formed by an endonucleolytic cleavage of longer pre-
mRNAs that is mechanistically different from the cleav-
age/polyadenylation reaction generating all other mRNA
3¢ ends. This 3¢ cleavage is itself cell cycle regulated.
* Corresponding author.
Moreover, the mature 3¢ end is involved in controlling
later steps of the RNA’s life cycle, such as translation and
mRNA degradation, the latter process being cell cycle
regulated as well.
Several reviews commenting these aspects of histone
RNA metabolism and focussing on the mRNA 3¢ end
have been written [1–5]. The purpose of this paper is to
discuss recent findings regarding the composition, func-
tion and cell biology of the U7 snRNP. These findings are
not only important for understanding histone pre-mRNA
and mRNA metabolism, but they are also relevant for
other fields, in particular those of riboregulation, the cell
biology of nuclear substructures and gene therapy.
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Role of the U7 snRNP in histone RNA processing
The histone RNA cleavage site is flanked by evolutionar-
ily conserved sequences that interact with trans-acting
processing factors (fig. 1). Upstream of the cleavage site
is a highly conserved 26 nt sequence encompassing a
hairpin structure. This RNA hairpin is recognised by the
hairpin binding protein (HBP) [6] or stem-loop binding
protein (SLBP) [7]. Because the hairpin sequence lies up-
stream of the cleavage site, HBP can remain bound to ma-
ture histone mRNA after 3¢ processing. In fact, HBP is as-
sociated in stoichiometric amounts with histone mRNA
on polysomes as well as in the nucleus [8, 9]. Moreover,
it has been implicated as a key player in other steps of hi-
stone mRNA metabolism besides RNA 3¢ end formation,
such as nucleo-cytoplasmic export, translation and the
cell cycle-specific degradation of histone mRNA at the
end of S phase [10–12]. Furthermore, HBP is essential
very early in development in both Drosophila mela-
nogaster [13] and Caenorhabditis elegans [14, 15].
The human HBP is 270 amino acids long and contains a
central RNA binding domain (RBD) of 75 amino acids
that was defined by deletion and point mutations [7,
16–19]. It does not resemble other known RNA binding
proteins. Similar to the cell cycle-specific regulation of
histone mRNA, HBP itself is also cell cycle regulated.
The protein accumulates to high levels in late G1 and dur-
ing S phases, followed by low levels during the rest of the
cell cycle. Both translational and posttranslational pro-
cesses, such as phosphorylation of HBP, contribute to this
regulation [20].
How does HBP enhance histone RNA 3¢ end processing?
Dominski et al. have determined that the minimal domain
required for processing in vitro consists of the RBD plus
the following 20 amino acids [21]. Furthermore, they
found that HBP acts by stabilising the binding of the U7
snRNP to the second conserved sequence element, the
purine-rich histone downstream element (HDE), con-
firming and extending previous work from our own
group [22, 23]. Moreover, a 100-kDa zinc finger protein
was identified that interacts with the HBP/RNA hairpin
complex but not with the individual components of this
complex [24]. This ZFP100 was shown to stabilise the in-
teraction between the HBP-bound histone pre-mRNA
and the U7 snRNP. Thus it seemed likely that ZFP100
might interact with one or more components of the U7
snRNP. Whether HBP and ZFP100, together, can account
for a previously described, but poorly characterised,
‘heat-labile factor’ [25], or whether other processing fac-
tors are required, is presently unknown.
The second conserved sequence in the histone 3¢ UTR,
the purine-rich HDE, lies several nucleotides downstream
of the cleavage site and interacts by base-pairing with the
U7 small nuclear (sn)RNA component of the U7 snRNP.
U7 snRNA is 57–71 nt long in the vertebrate and inver-
tebrate species in which it has been characterised. Soon
after its initial discovery in sea urchins [26, 27], it was
found to have a trimethyl-guanosine cap structure and to
interact with proteins recognised by anti-Sm antibodies
[28]. These features characterised it as a member of the
Sm-type snRNPs, along with most spliceosomal snRNPs.
The U7 RNA structure is simple, consisting of a short 5¢
end accessible to nucleases followed by a somewhat de-
generate Sm binding site involved in snRNP assembly
and a 3¢-terminal hairpin required for stability [29]. The
exposed 5¢ end is complementary to the HDE in both ver-
tebrate and invertebrate histone pre-mRNAs. The func-
tional importance of this sequence complementarity for
histone RNA 3¢ end processing has been proven using
complementary mutations in U7 and histone RNAs [23,
30, 31].
In addition to being necessary for RNA 3¢ processing, U7
snRNA plays the role of a ‘molecular ruler’ that positions
the cleavage activity close to the appropriate phosphodi-
ester bond. When the distance between the HDE and the
hairpin in histone pre-mRNA is increased, the processing
site gets shifted in the 3¢ direction by a corresponding
number of nucleotides [32]. Moreover, when correspond-
ing length insertions are made between the Sm binding
site and the base-pairing region of U7 snRNA, the cleav-
age site can shift back as predicted by the ruler model, but
only if the inserted sequences are complementary to those
present in the histone pre-mRNA [33]. Additionally, the
Figure 1. Molecular mechanism of histone pre-mRNA 3¢ end pro-
cessing. Animal replication-dependent histone pre-mRNAs contain
all the cis-acting sequences necessary for 3¢ end processing: a hair-
pin with a 6-bp stem and a 4-nucleotide loop that is bound by the
hairpin-binding protein (HBP) and the histone downstream element
(HDE) that tethers the m3G-capped U7 snRNA by base-pairing in-
teractions. HBP functions by stabilising the association of the U7
snRNP with the pre-mRNA [21]. It is helped in this role by a 100-
kDa zinc finger protein (ZFP100) [24] that forms a molecular
bridge between HBP and the U7 snRNP [37]. The special Sm core
structure of the U7 snRNP contains five Sm proteins that are also
found in spliceosomal snRNPs (blue) and two U7-specific proteins,
Lsm10 and Lsm11 (orange; see fig. 2) [36, 37]. The 3¢ end of the
mature histone mRNA is generated by an endonucleolytic cleavage
at the extremity of the ACCCA sequence which immediately fol-
lows the hairpin. HBP remains bound to the mature mRNA and
functions in several downstream events, such as nucleo-cytoplas-
mic export, translation and stability.
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cleavage efficiency at the selected position depends on an
optimal phosphodiester bond (ideally 3¢ of an adenosine)
and on the appropriate juxtaposition between the hair-
pin/HBP and the U7 snRNP [33, 34].
After the cleavage has occurred, a 5¢ exonuclease de-
grades the cut-off 3¢ fragment of histone pre-mRNA and
thereby helps to recycle the U7 snRNP [35].
After several unsuccessful attempts in different laborato-
ries, we recently succeeded in purifying U7 snRNPs from
HeLa cells in sufficient quantities to characterise the U7
snRNP-associated proteins. These studies revealed that
U7 snRNPs contain all but two of the seven Sm proteins
(fig. 2). In place of the missing Sm D1 and D2 proteins,
additional polypeptides of 14 and 50 kDa are present. Mi-
crosequencing identified the 14-kDa polypeptide as a
new Sm-like protein related to Sm D1 and D3, which we
termed Lsm10 [36]. The 50-kDa polypeptide also proved
to be a member of the Sm/Lsm protein family, albeit a
highly unusual one, and it was consequently termed
Lsm11 [37]. Its two Sm motifs are separated by 138
amino acids and preceded by an N-terminal extension of
170 residues (see below and fig. 3).
Earlier studies from our laboratory had shown that con-
verting the non-canonical Sm binding site of U7 snRNA
(AAUUUGUCUAG; U7 Sm WT) into the consensus se-
quence derived from spliceosomal snRNPs (AAUUUU-
UGGAG; U7 Sm OPT; fig. 2) resulted in snRNP particles
that accumulated more efficiently in the nucleus but were
Figure 2. The unique Sm core structure of U7 snRNPs. Whereas
spliceosomal snRNPs contain an Sm core structure consisting of
the seven standard Sm proteins B/B¢, D3, D1, D2, E, F and G (right)
[41, 46, 98], the U7 snRNP (left) has two U7-specific Sm-like pro-
teins, Lsm 10 and 11 (orange) replacing Sm D1 and D2 [36, 37]. In
comparison with other Sm/Lsm proteins, Lsm11 has an extended
N-terminus (N) and a long linker (L) between its two Sm motifs (see
fig. 3). The N-terminus participates in the histone processing reac-
tion by directly interacting with ZFP100 (see fig. 1). Converting the
special U7 snRNA Sm binding site (U7 Sm WT) to a consensus de-
rived from the spliceosomal snRNAs (U7 Sm OPT) leads to the for-
mation of an Sm core containing D1/D2. Assembly of these two
structures is mediated by distinct SMN complexes containing either
of the two dimers, Sm D1/D2 or Lsm10/11 [37]. The zig-zag line
extensions of B/B¢, D1 and D3 denote Arg-Gly dipeptide repeats
containing symmetrical dimethylarginine modifications introduced
by the PRMT5 methyltransferase complex [78, 79].
non-functional in histone RNA processing [38, 39]. Thus
it seemed likely that the U7 Sm WT and U7 Sm OPT
snRNPs would differ by the presence of Lsm10/11 and
Sm D1/D2, respectively, and that at least one of the U7-
specific Lsm proteins might be functionally involved in
histone RNA 3¢ processing. This hypothesis could be cor-
roborated experimentally [37]. More specifically, we
could ascribe an essential function in histone RNA pro-
cessing to the N-terminal extension of Lsm11. At least
part of this contribution appears to be mediated by an in-
teraction between the N-terminus of Lsm11 and ZFP100.
Thus, HBP, ZFP100 and Lsm11 form a sort of molecular
bridge between the histone pre-mRNA and U7 snRNA
(fig. 1). This not only stabilises this RNA:RNA interac-
tion but also provides additional binding specificity.
What is still unknown is how the actual RNA cleavage
occurs. Are the presently characterised processing factors
sufficient or are additional components still awaiting
their discovery? The low abundance of the factors in-
volved and difficulties with expressing native recombi-
nant proteins turns a full reconstitution of the system into
a virtually insurmountable task. Most likely, a combina-
tion of genetic and biochemical approaches will be re-
quired to resolve this important question.
A new type of Sm/Lsm protein structure involved in
riboregulation
Originally, the Sm proteins were so named because they
react with antibodies of the Sm serotype from patients af-
fected by the autoimmune disease systemic lupus erythe-
matosus [40]. The corresponding antigens are compo-
nents of the spliceosomal snRNPs U1, U2, U4 U5, U11,
U12 and U4atac. As these snRNPs were purified, they
were each found to contain a set of seven small proteins
which were termed Sm proteins B/B¢ (alternative splicing
products of the same gene), D1, D2, D3, E, F and G (re-
viewed in [41]). The widely used Y12 monoclonal anti-
Sm antibody reacts to a variable extent with Sm B/B¢, D1
and D3. Later it was revealed that these proteins share
conserved amino acid residues that define a new family
of proteins [42–44]. These residues form the Sm motifs
1 and 2, which are separated by a short, but variable linker
(fig. 3). X-ray structures of co-crystals of either Sm B/D3
or D1/D2 showed identical folding patterns of all four
proteins and identical subunit interfaces for the two het-
erodimers [45, 46]. Based on this structural similarity as
well as on a host of other biochemical data, it was pro-
posed that one molecule each of the seven Sm proteins
form a seven-membered ring structure, the so-called Sm
core (fig. 2). Additional evidence for such a structure was
obtained from cryo-electron microscopy of purified U1
snRNPs [47] and from crystal structures of related com-
plexes from Archeal proteins (see below).
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In addition to the standard Sm proteins, all eukaryotes
have additional proteins containing the Sm domain, the
so-called Sm-like or Lsm proteins [42, 44, 48–51, re-
viewed in 52]. Interestingly, these proteins exist in at
least three structures that differ in function but overlap in
their polypeptide composition. Thus, Lsm 2–8 form a
heptameric ring around the 3¢-terminal oligo-U stretch
of U6 snRNA in the U6 mono-snRNP, the U4/U6 di-
snRNP and the U4/U6 · U5 tri-snRNP [42, 44, 50]. In
this context, these Lsm proteins are important for U6
snRNP recycling during pre-mRNA splicing [48, 50, 53,
54]. Unlike the Sm proteins, Lsm 2–8 can form a hep-
tameric ring complex in the absence of U6 snRNA [48].
Most of these spliceosomal Lsm proteins have an identi-
fiable closest relative among the standard Sm proteins,
suggesting that the two heptameric units may have arisen
by a coordinate gene duplication event. The second type
of Lsm structure has Lsm1 replacing Lsm8: Lsm 1–7
form a cytoplasmic, rather than nuclear, complex that
mediates mRNA decapping and 5¢-exonucleolytic degra-
dation [52, 55, 56]. Furthermore, Lsm 2–7 were recently
shown to associate with snR5, a yeast box H/ACA small
nucleolar (sno)RNA that functions to guide site-specific
pseudouridylation of rRNA [57]. Additional functions
for some Lsm proteins in the U8 snoRNP [58] and in
transfer RNA (tRNA) maturation [59] have also been re-
ported. Thus, by mixing and matching different proteins
from this family, the cell can create different complexes
with distinct functions.
Proteins of the Sm/Lsm family have also been identified
in Archaea and in Eubacteria. Archaea usually have only
one or two different Lsm proteins that form homohep-
tameric or -hexameric rings [60, 61]. In Escherichia coli,
the long-known Hfq protein (host factor for Qb) was re-
cently shown to be an Lsm protein [62, 63]. Hfq associ-
ates with multiple short non-coding regulatory RNAs that
modulate the translation or stability of target mRNAs via
an antisense recognition mechanism. Moreover, like the
archaeal Lsm proteins, Hfq has a very similar three-di-
mensional (3D) structure as the mammalian Sm proteins
and assembles into homohexameric rings [62–64]. Thus
the Sm/Lsm protein family is very ancient, and its mem-
bers build similar structures and are involved in various
mechanisms of riboregulation in all three domains of life.
The U7 snRNP represents a new theme among these
Sm/Lsm ring structures. In contrast to the structures con-
taining Lsm 1–7, Lsm 2–8 or Lsm 2–7 where a single
subunit is either replaced or missing, the U7 Sm core dif-
fers by two subunits compared to the spliceosomal
snRNPs. The two Sm proteins missing from the U7
snRNP, D1 and D2, have been shown to form a het-
erodimer that acts as an intermediate of Sm core assem-
bly in spliceosomal snRNPs [65, 66] (see below). A sim-
ilar heterodimer is also formed by Sm D3 and B/B¢,
whereas Sm E, F and G form F/E/G trimers or (F/E/G)2
hexamers. Interestingly, Lsm10 and the Sm domain of
Lsm11, when co-expressed in E. coli, also form a het-
erodimeric complex [R.S.P. and D.S., unpublished re-
Figure 3. Lsm11 is an unusual member of the Sm/Lsm protein family. Sm and Lsm proteins share conserved amino acids defining the Sm
motifs 1 and 2 that are separated by a usually short, variable linker [43, 44, 48, 49, 51]. Together, these form a defined structure – the Sm
domain – consisting of an a-helix and five b-strands [45, 46]. The Sm proteins Sm D1, D3 and B/B¢ have RG repeats (indicated by black
bars; interrupted by non-RG sequences for D3 and B/B¢). These repeats contain symmetrical dimethylarginine modifications introduced
by the PRMT5 methyltransferase complex [78, 79]. Of the two U7-specific proteins, Lsm10 is most similar to Sm D1 and D3 but lacks RG
repeats [36], while Lsm11 is closest to Sm D2, which has a moderately long N-terminus and a somewhat longer linker between its Sm mo-
tifs. Lsm11 stands apart from other Sm proteins with its unusually long linker and N-terminus. The N-terminus of Lsm11, which participates
in histone processing contains four patches of amino acids that show conservation from vertebrates to invertebrates (grey boxes) [37, 67].
The numbers indicate the lengths of different segments in amino acids.
sults]. Moreover, Lsm10 most closely resembles one of
the proteins in the two other Sm heterodimers, i.e. Sm D1
and D3 [36]. By extension, it is also similar to the D1 and
D3 ‘relatives’ among the spliceosomal Lsm proteins,
Lsm2 and Lsm4, respectively. Although Sm B/B¢, D2 and
Lsm11 share little more than a weak similarity in their Sm
motifs and longer than average spacers between these, it
can be speculated that the appearance of a heterodimer
consisting of a D1-like and a D2-like protein may have
been an early step in Sm/Lsm protein diversification in
early eukaryotes. In this evolutionary scheme, each of the
present pairs could have arisen by duplication of an exist-
ing dimer and by subsequent co-evolutionary diversifica-
tion of both partners within a dimer. Presumably, Lsm10
and Lsm11 were added last, coincident with the advent of
the U7-snRNP-dependent histone RNA 3¢ end processing
mechanism in metazoans.
Another novel aspect of the U7 Sm/Lsm core structure is
the fact that Lsm11 contains long amino acid stretches at
its N-terminus and between the two Sm motifs (fig. 3),
and that the N-terminus plays a functional role in histone
RNA processing (see above). Although the precise mech-
anism has not been elucidated, this functional contribu-
tion to a biochemical reaction is so far unique among the
Sm/Lsm proteins. Bioinformatic analyses have revealed
orthologs of Lsm10 and Lsm11 in most vertebrates, in tu-
nicates and in arthropods, and the Drosophila orthologs
have been characterised biochemically [67]. These stud-
ies also indicated that the N-terminus of Lsm11 contains
four patches of evolutionarily conserved amino acid
residues that are most likely parts of a-helices, whereas
the remainder of the N-terminus is quite divergent (fig.
3). A detailed analysis of these conserved parts of the pro-
tein are likely to provide further insights into the func-
tion(s) of Lsm11.
Implications for snRNP assembly and subnuclear ar-
chitecture
The challenge facing the cell in assembling Sm proteins
onto the Sm binding site of U snRNAs, essentially a U-
rich sequence, is daunting, considering that the chance of
finding such a sequence in the transcriptome is quite
high. In fact, in vitro assembly reactions performed with
purified Sm proteins show that they assemble sponta-
neously not only with U snRNAs but also with other
RNAs like tRNA and ribosomal RNA (rRNA) which are
very abundant in the cell [68]. The special composition of
the U7 Sm core and its functional importance for histone
RNA processing pose a further specificity problem for
the assembly of U snRNPs. The essential function of
Lsm11 in histone RNA processing and the fact that U7
Sm OPT snRNPs are deficient in histone RNA process-
ing (see above) [39] indicate that U7 snRNPs incorporat-
ing Sm D1 and D2 would be non-functional and might
even be inhibitory for histone RNA processing. Con-
versely, Sm D1 and D2 might have specific functions in
spliceosomal snRNPs. Thus, the cell should have effec-
tive means to prevent such potentially detrimental associ-
ations of ‘wrong’ Sm/Lsm proteins with a given snRNA.
The assembly of all snRNPs except for U6 follows a nu-
cleo-cytoplasmic shuttling pathway (reviewed in [46]).
The U snRNAs are transcribed by RNA polymerase II in
the nucleus and then get exported to the cytoplasm where
they assemble with stockpiled Sm proteins. Once the hep-
tameric Sm core has been formed, the 7-methyl guano-
sine cap of the RNA is hypermethylated to 2,2,7-
trimethyl guanosine. This trimethyl cap is recognised by
the specialised transport adaptor snurportin, which coop-
erates with importin b [69], and the snRNP particle is re-
imported into the nucleus.
As mentioned above, purified Sm proteins form specific
hetero-oligomeric complexes consisting of B/B¢-D3, D1-
D2 and F-E-G, which can then spontaneously assemble
onto the Sm site of a U snRNA [65, 66]. However, in vivo,
Sm core formation is an ordered, protein-assisted process.
An important factor regulating this assembly is the ‘sur-
vival of motor neurons’ (SMN) protein, which is mutated
in the fatal neuromuscular disorder spinal muscular atro-
phy (SMA). SMN exists in the cell as a multiprotein com-
plex along with several stably associated proteins called
Gemins and varying amounts of the common Sm proteins
(reviewed in [70, 71]). This SMN complex is both neces-
sary and sufficient to assemble Sm cores on spliceosomal
snRNAs in an ATP-dependent manner [68, 72, 73]. Recent
evidence also suggests that the SMN complex may act as
a specificity factor guarding against illicit association of
Sm proteins with other RNAs [68]. Indeed, the specificity
is attained only by Sm proteins that are already part of the
SMN complex, and in vivo, Sm protein association with
the SMN complex precedes their assembly onto U snR-
NAs [73]. To achieve the full specificity, the SMN com-
plex interacts not only with the Sm proteins but also with
the U snRNAs via specific SMN binding domains that
may or may not overlap with the Sm binding site, depend-
ing on the particular snRNA involved [74, 75]. In vivo, the
SMN complex is associated with the snRNAs throughout
their cytoplasmic assembly phase [76].
Concerning the U7 snRNP, early studies using microin-
jected Xenopus laevis oocytes indicated that its assembly
pathway is similar to the one for spliceosomal snRNPs
[39]. Later it was found that U7 snRNP assembly in cell-
free extracts from Xenopus eggs which yields functional
U7 snRNPs [77] is ATP dependent and mediated by the
SMN complex [37]. In this in vitro system, as in vivo,
converting the U7 Sm binding site to Sm OPT, the con-
sensus derived from spliceosomal snRNPs, results in as-
sembly with the Sm proteins D1 and D2 instead of Lsm10
and Lsm11. Moreover, the resulting U7 Sm OPT snRNPs
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are also non-functional in histone RNA processing. This
implies that the SMN complex must be able to recognise
and specifically combine the U7-specific Lsm10 and
Lsm11 proteins and the Sm binding site of U7 snRNA.
This could in principle be achieved by an SMN complex
containing all Sm proteins as well as Lsm10 and Lsm11.
However, the role of the SMN complex as a specificity
chaperone would be facilitated by having separate pre-
formed SMN complexes containing either of the two pro-
tein dimers SmD1/D2 or Lsm10/11 along with the other
five Sm proteins. Indeed, our recent studies have pro-
vided evidence for two separate entities containing SMN
and the five common Sm proteins, one containing
Lsm10/Lsm11 and the other containing Sm D1/D2 [37].
Only the Lsm10/11-containing SMN complexes can me-
diate the assembly of the U7 snRNP, whereas complexes
that contain the seven canonical Sm proteins fail in the
same reaction, but assemble D1/D2-containing Sm core
structures on U1 or U7 Sm OPT RNA. How these two
mutually exclusive sets of Sm/Lsm proteins get incorpo-
rated into the SMN complex will be an interesting topic
for further investigations.
Another complex participating in the assembly process,
perhaps more at the level of its regulation, is the PRMT5
complex containing the PRMT5 protein methyltrans-
ferase, pICln, WD45 and possibly other protein subunits
[78, 79]. This complex can convert the arginines in the C-
terminal RG repeats of the Sm proteins B/B¢, D1 and D3
(figs 2, 3) to symmetrical dimethyl arginines (sDMAs).
Within the complex, the pICln subunit binds to the Sm
domains of these substrate proteins, and PRMT5 per-
forms the modification step. Clues to the functional con-
sequence of these modifications came from the finding
that their presence increases the affinity of Sm B/B¢, D1
and D3 for the SMN complex. This suggests a sequence
of events where the PRMT5 complex pre-assembles,
modifies and presents these Sm proteins to the SMN
complex, which then uses them for Sm core assembly.
Additional known substrates for sDMA methylation, pos-
sibly also mediated by the PRMT5 complex, are Lsm4,
myelin basic protein and coilin.
The PRMT5 complex may also play an additional role in
snRNP assembly that is not related to methylation. This is
at least suggested by our recent findings indicating that
Lsm10 and Lsm11 interact with the PRMT5 complex in
vivo and with pICln in vitro, although none of them has
RG repeats and their binding to SMN is independent of
methyltransferase activity [R.S.P. et al., unpublished re-
sults). Moreover, a larger complex containing all compo-
nents of the PRMT5 and SMN complexes was recently
isolated, and the presence of the PRMT5 complex com-
ponents had an ATP-dependent stimulatory effect on the
SMN-mediated snRNP assembly activity in vitro [73].
In the nucleus, the snRNPs are found concentrated in Ca-
jal bodies (CBs), as well as diffusely distributed through-
out the nucleoplasm, where they are stored in so-called
interchromatin granules and used for splicing in perichro-
matin fibrils (reviewed in [80]). In fact, newly-assembled
snRNPs target first to the CBs [81]. At least one function
of CBs is the introduction of sugar 2¢-O-methyl and
pseudouridine base modifications on some U snRNAs,
guided by small CB-specific RNAs (scaRNAs) [82]. In-
terestingly, SMN is also found in CBs in most cells. It is
held there by a specific interaction with coilin, the marker
protein for CBs. This interaction is dependent on sDMA
modifications of RG repeats in coilin, and hypomethyla-
tion of these repeats leads to relocalisation of SMN in
separate nuclear structures termed “gemini of CBs” or
“gems” [83]. CBs are likely to have other functions which
are still not fully understood. Also, components of
snoRNPs and of polyadenylation complexes are tran-
siently found associated with them (reviewed in [80]).
Whereas mammalian CBs contain both U7 and spliceoso-
mal snRNPs [84], a special situation prevails in Xenopus
oocytes. There, the U7 snRNP is a major and perhaps the
only snRNP component of the large CBs, which are also
called spheres or C snurposomes [85]. In contrast, the
spliceosomal snRNPs are found in structures lacking
coilin that are termed B snurposomes. Overexpression of
U7 snRNA leads to the formation of additional CBs [86].
Moreover, the non-canonical Sm binding sequence of U7
RNA was shown to be responsible for correct localisation;
replacing it by an Sm binding sequence from U2 snRNA
led to a failure in CB localisation [87]. Thus, in Xenopus
oocytes, the U7-specific Lsm proteins might have a role in
targeting the U7 snRNP to the spheres or C snurposomes,
which often associate with the histone gene loci.
U7 snRNA derivatives as tools for nuclear antisense
therapy
The above basic studies on the U7 snRNP, and in partic-
ular the properties of the U7 Sm OPT snRNA containing
a consensus Sm binding sequence derived from spliceo-
somal snRNAs, engendered an idea to use modified U7
snRNA derivatives for a special antisense therapy ap-
proach. It has already been mentioned that U7 Sm OPT-
derived snRNPs (which contain Sm D1/D2 instead of
Lsm10/11) are deficient in histone RNA processing. In
fact, such snRNPs were even found to exert a dominant
negative effect in Xenopus oocytes that still contained
functional, endogenous U7 snRNPs [B. Stefanovic and
D.S., unpublished results]. This dominant negative effect
was based on a competition for the HDE, as U7 Sm OPT
derivatives with an altered base-pairing region were only
deficient, but not dominant negative. We hypothesised
that if U7 Sm OPT-derived snRNPs can compete with the
histone 3¢ processing machinery, they should also be able
to block specific pre-mRNA splicing events which occur
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in the same compartment, the nucleoplasm. Hence, U7
Sm OPT-derived RNAs equipped with antisense se-
quences targeting specific splice sites, with their exclu-
sively nuclear location and their inability to cleave the tar-
get pre-mRNA, should be ideally suited to manipulate the
splicing patterns of individual target genes.
This approach was modeled on a strategy pioneered by
Kole et al., where antisense oligonucleotides are used to
target specific splice sites in pre-mRNAs and, hence, to
redirect alternative splicing decisions (reviewed in [88]).
Oligonucleotide-based redirection of splicing can be ben-
eficial for many inherited diseases such as b-tha-
lassemias, muscular dystrophy and cystic fibrosis, or it
can be used to affect the fine-tuning of the apoptotic re-
sponse, e.g. in cancer cells. However, if these antisense
sequences are expressed from an snRNA-encoding gene
such as a modified U7 Sm OPT derivative, more sus-
tained or even permanent nuclear antisense effects may
be achieved. Work carried out in several different labora-
tories, including ours, has demonstrated that this is more
than a remote possibility. Rather, U7-based approaches
have proven to be effective in different systems and have
been tested not only in tissue culture but also in in vivo
situations.
Initial work, using a tissue culture model for b-tha-
lassemia, confirmed the practicability of this approach
[89–91]. Several mutations in the second intron of the
human b-globin gene create 5¢ splice sites (IVS2-654, -
705 and -745) and activate a common cryptic 3¢ splice
site (ss) further upstream in the same intron. This results
in the inclusion of an aberrant exon in b-globin mRNA
and in the loss of b-globin protein production (fig. 4).
Several U7 Sm OPT derivatives targeting the cryptic 3¢ ss
or the 5¢ ss created by the mutations were able to mask
these ss, resulting in the reappearance of correctly spliced
b-globin mRNA and protein. However, although these ef-
fects were efficient for the IVS2-705 and -745 mutations,
they were weak for the IVS2-654 mutation. An improved
efficiency for all three mutations was obtained with U7
snRNA derivatives carrying two tandem antisense se-
quences, one targeting the branch point region upstream
of the aberrant exon or the cryptic 3¢ ss, and the other tar-
geting the end of the exon, including its 5¢ ss (fig. 4) [90].
This double-target approach has proven to be very effec-
tive as a means to induce exon skipping in the context of
other transcription units such as the human [92] or mouse
[93] dystrophin gene, the cyclophilin A gene [94] or the
multiply spliced HIV-1 transcripts [G. Marti et al., un-
published results].
Other workers have also obtained efficient exon skipping
when the U7 snRNA derivative carried a sequence com-
plementary to exon-internal sequences [95]. In this case,
the U7 may have acted by masking exonic splicing en-
hancer (ESE) sequences or by affecting the flexibility of
the exon. We have also found a double-target construct
targeting a bona fide ESE and the downstream 5¢ ss to be
very effective in the context of the human immunodefi-
ciency virus-1 (HIV-1) transcription unit [G. Marti et al.,
unpublished results].
In addition to these exon skipping strategies, a U7 Sm
OPT derivative has also been used to enhance the inclu-
sion of an exon that is normally skipped, probably due to
the lack of an exonic splicing enhancer, in the survival of
motor neurons 2 (SMN2) gene. This exon inclusion was
achieved with a U7 snRNA that masks the 3¢ ss of the
subsequent exon [K. J. Hertel, personal communication].
Moreover, a U7 snRNA has been provided with an RNA
decoy that will sequester an RNA binding protein re-
sponsible for high levels of collagen alpha1(I) mRNA in
hepatic stellate cells [96].
Modified derivatives of the spliceosomal U1 snRNA have
similarly been used to target nuclear splicing events. How-
ever, in direct comparisons, such U1 constructs were gen-
erally not more efficient than corresponding U7 con-
structs [92, 97]. Moreover, replacing the U7 promoter by
Figure 4. Modified U7 snRNPs as precision tools to affect splicing
decisions. Several mutations in the second intron of the human b-
globin gene cause b-thalassemia. These mutations create 5¢ splice
sites at positions 654, 705 or 745 of the second b-globin intron
(top). This activates a cryptic 3¢ splice site (cr 3¢ ss) upstream in the
same intron, resulting in the inclusion of an aberrant exon contain-
ing an early stop codon and, therefore, in the loss of b-globin pro-
tein production. U7 Sm OPT snRNAs modified to base-pair with
either the cr 3¢ ss or 5¢ ss (single-target constructs) efficiently redi-
rect splicing to generate functional b-globin mRNA and protein for
the IVS-705 and -745 mutations, but inefficiently for IVS2-654
[89, 90]. U7 snRNAs that base-pair simultaneously to two regions
upstream and downstream of the aberrant exon (double-target con-
structs), perhaps looping out the region between the two base-pair-
ing sites, show an improved exon skipping efficiency, also for the
IVS2-654 mutation. 
the U1 promoter also did not significantly increase the
levels of the snRNA or the antisense effect on splicing [93,
97]. These findings are consistent with our earlier analy-
ses, which showed that the ~100-fold difference in steady-
state levels between endogenous U1 and U7 snRNAs can
be accounted for by differences in functional gene copy
number (~30-fold) and snRNP assembly (2–4-fold) [38].
In particular, exchanging promoters and 3¢ regions or, in
fact, most of the RNA coding regions between a U1 and a
U7 gene had no significant effects on steady-state RNA
levels. Rather, the 2–4-fold difference in RNA levels per
gene was found to be primarily controlled by the respec-
tive Sm binding site, and replacing the U7 Sm binding site
by the consensus Sm OPT sequence led to similar levels
of RNA accumulation as from a U1 gene [38]. Thus U7
and U1 genes have similar transcriptional activities, and
U7 Sm OPT can be regarded as a well-expressed,
‘generic’ snRNA that is particularly well suited for the in-
sertion of extended antisense sequences at its 5¢ end. Nev-
ertheless, it may be possible to improve the U7 promoter
by design: in one study, the expression of an antisense U7
snRNA in cultured myoblasts was stimulated by the inser-
tion of the muscle creatine kinase enhancer [93], indicat-
ing that the U7 gene may respond to cell type-specific or
even regulatable enhancer sequences.
For delivery into suspension cell lines, primary cells from
patients or laboratory animals, standard DNA transfec-
tion protocols are usually not efficient. In this context, 
the small size of the U7 snRNA expression cassette
(~600 bp) allows its insertion into virtually any vector,
including viral ones that allow for stable DNA inte-
gration. Thus, U7 expression cassettes have been success-
fully introduced into a variety of cell types, including 
primary cells,  by using retroviral [92], lentiviral [94, 95],
[G. Marti et al., unpublished results], and adeno-associ-
ated viral vectors [L. Garcia, personal communication].
The modulation of splicing obtained with U7 snRNA
constructs has generally been found to be very specific.
Although ~1000 RNA copies can generally be expressed
in most cells, toxic side effects have not been observed,
and the desired antisense effect should only be exerted in
those cells expressing the targeted pre-mRNA. For one
U7 construct targeting thalassemic mutations in the hu-
man b-globin gene, transgenic mice have been generated
that transmit and express the gene and that show no obvi-
ous defects [D. S., unpublished results]. All these features
contribute to making antisense U7 snRNA an attractive
tool for posttranscriptional gene modulation.
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